EXL Reports 2025 Third Quarter Results GlobeNewswire October 28, 2025 2025 Third Quarter Revenue of $529.6 Million, up 12.2% year-over-year Q3 Diluted EPS (GAAP) of $0.36, up 10.7% from $0.33 in Q3 of 2024 Q3 Adjusted Diluted EPS (Non-GAAP) (1) of $0.48, up 10.8% from $0.44 in Q3 of 2024 NEW YORK, Oct. 28, 2025 […]
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025 Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT GlobeNewswire October 28, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today
Expand Energy Corporation Reports Third Quarter 2025 Results GlobeNewswire October 28, 2025 OKLAHOMA CITY, Oct. 28, 2025 (GLOBE NEWSWIRE) — Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy” or the “Company”) today reported third quarter 2025 financial and operating results. Net cash provided by operating activities of $1,201 million Net income of $547 million, or $2.28
Kura Oncology to Report Third Quarter 2025 Financial Results GlobeNewswire October 28, 2025 SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report third quarter 2025 financial results on Tuesday,
Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 28, 2025 HOLLISTER, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will
BridgeBio to Report Phase 3 Results for Encaleret in ADH1 CALIBRATE Study on Wednesday, October 29th GlobeNewswire October 28, 2025 PALO ALTO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced plans to release topline results
(NASDAQ:RVSB), FISCAL Q2 2026 HIGHLIGHTS $1.1 Million $0.05 $6.51 0.05% Net Income Diluted Earnings per Common Share Tangible Book Value per Share NPAs to Total Assets Fiscal Second Quarter Comparison Highlights Net Interest Income and Net Interest Margin $9.8 million net interest income for the quarter compared to $8.9 million in Fiscal Q2 2025 Net
(NASDAQ:MDAI),(NASDAQ:MDAIW), DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2025 on Tuesday,
(NASDAQ:YDDL), San Rafael, Bulacan, Philippines, Oct. 28, 2025 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (the “Company”) (NASDAQ: YDDL), a waste materials and scrap metal recycling company in the Philippines, today announced the full exercise of the over-allotment option by the underwriter of its initial public offering (the “Offering” or the “IPO”) to
(NASDAQ:KTOS), SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, announced today that it will publish financial results for the third quarter 2025 after the close of market on Tuesday, November 4th. Management will discuss the Company's